Siirry pääsisältöön
Käyttämääsi selainta ei enää tueta – lue lisää.
0,0094SEK
+20,51% (+0,0016)
Päätöskurssi
Ylin0,0094
Alin0,0070
Vaihto
0,6 MSEK
0,0094SEK
+20,51% (+0,0016)
Päätöskurssi
Ylin0,0094
Alin0,0070
Vaihto
0,6 MSEK
0,0094SEK
+20,51% (+0,0016)
Päätöskurssi
Ylin0,0094
Alin0,0070
Vaihto
0,6 MSEK
0,0094SEK
+20,51% (+0,0016)
Päätöskurssi
Ylin0,0094
Alin0,0070
Vaihto
0,6 MSEK
0,0094SEK
+20,51% (+0,0016)
Päätöskurssi
Ylin0,0094
Alin0,0070
Vaihto
0,6 MSEK
0,0094SEK
+20,51% (+0,0016)
Päätöskurssi
Ylin0,0094
Alin0,0070
Vaihto
0,6 MSEK
2025 Q4 -tulosraportti

Vain PDF

4 päivää sitten

Tarjoustasot

SwedenSpotlight Stock Market SE
Määrä
Osto
1 000 000
Myynti
Määrä
376 693

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
10 638AVAAVA
4 178 113AVAAVA
125 000NONAVA
319 148AVAAVA
255 320AVAAVA
Ylin
0,009
VWAP
0,009
Alin
0,007
VaihtoMäärä
0,6 72 983 419
VWAP
0,009
Ylin
0,009
Alin
0,007
VaihtoMäärä
0,6 72 983 419

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt

Yhtiötapahtumat

Datan lähde: FactSet, Quartr
Seuraava tapahtuma
2026 Q1 -tulosraportti
7.5.
Menneet tapahtumat
2025 Q4 -tulosraportti
11.2.
2025 Q3 -tulosraportti
12.11.2025
2025 Q2 -tulosraportti
20.8.2025
2025 Q1 -tulosraportti
7.5.2025
2024 Q4 -tulosraportti
13.2.2025

Shareville

Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
  • 1 päivä sitten
    ·
    1 päivä sitten
    ·
    It's really taking off today. I wonder if it's due to the earnings report or because some investors have noticed that it has risen a bit recently?
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    If you have followed this case and thus know its history, you will know - that the case is moving towards the point, this year / next year - where a partnership with one/several regional/international partners from the current valuations will make the case explode. It is pure positioning in HOPE that it actually happens. ....and does it happen then? Who knows, the case is still a pure lottery ticket, nobody can tell...... Having said that, at the same time a lottery ticket for a supplier who has proven to be able to perform quantitative analysis down to the individual sperm cell - and even has a patent on the entire methodology - in an ART market that is predicted by the UN in 2030 to amount to somewhere between 40 and 70 BILLION USD - which in round figures is somewhere between 250 and 450 BILLION DKK in annual ART treatment. Sooo..... that...... Ladies & Gentlemen, Bet's Please!!......
  • 5.2.
    ·
    5.2.
    ·
    It is difficult to come
    9.2.
    ·
    9.2.
    ·
    Many men feel that way😂 apropos this case😂
  • 5.2.
    ·
    5.2.
    ·
    Don't sell too cheaply now. Suddenly it will rise to heights, I believe Spermosens is getting a foothold in several places. This is not a buy recommendation, just a feeling, a strong feeling.
  • 4.2.
    ·
    4.2.
    ·
    Wonder if T06 is advantageous
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    If you like lottery tickets, then buy. I don't really, but you can see in my portfolio how many mio. I have bought.
  • 21.1.
    ·
    21.1.
    ·
    So there have again been a number of news that one can reasonably call positive regarding collaborations (well, non-binding for now). In recent days, there has been a gradual increase up to the level the stock had 6 months ago, which is nice after such a long period of falling prices. It will be very interesting to see if things are turning around for Spermosens now. I think it's too early to say, as there's nothing concrete in the form of contracts, sales or similar, but when/IF it turns around, I have a feeling that there could be some strong price increases. For now, however, I will keep a cool head and wait. I own a number of shares in Spermosens and this is NOT A RECOMMENDATION TO BUY OR THE OPPOSITE, BUT MERELY SOME THOUGHTS. I look forward to the financial report and especially the management's statement on the company's progress.
    22.1. · Muokattu
    ·
    22.1. · Muokattu
    ·
    The global fertility is generally declining - for several reasons, including poor sperm quality. The UN estimates that the average global fertility rate will drop to 2.1 per woman by 2050, which is not that far away. The UN estimates that the world population will stagnate around 2080. .......that was the helicopter view. And now back to something a bit more down-to-earth, there's money in fertility - a lot of money! ChatGPT states that the global ART treatment market in 2030 will amount to somewhere between 40 and 70 BILLION USD - which in round figures is somewhere between 250 and 450 BILLION DKK in annual ART treatment. ........and then there's a small candy shop in Lund that has cracked the code on how quantitative analysis can be performed right down to the individual sperm cell - and they even have a patent on what they're fiddling with☝️☝️ I take the view that the small candy shop constitutes a far more attractive lottery ticket than any product that can be found on spil.dk☝️☝️ .....a lottery ticket, yes - one should certainly not be mistaken about that☝️☝️ In my opinion, the leaflet on that bandit simply states a completely different probability of winning than what can be read on the aforementioned spil.dk☝️☝️ Seen from a TA technical perspective, the case has broken the 20MA upwards on a daily chart level, the same 20MA will break up on a weekly chart level at a closing price over 0.065 - i.e., just a bit above today's closing price. There are technical traders who declare this a buy signal, often in combination with several other signals, including MACD- / RSI- convergence. Personally, I don't attach the same value to it - not least not in a tiny-tiny-candy factory like SPERM - but as the technical trader I am, I naturally can't help but notice the momentum that it also indicates somewhere...... DISCLAIMER: This post should solely be read as my interpretation of the case SPERM constitutes, and should IN NO WAY be perceived as an encouragement to others to invest money in the stock. I have a position in the case. Do your own analyses, and feel free to seek professional guidance before exposing capital in the financial markets, including possibly in SPERM☝️☝️
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Uutiset

AI
Viimeisin
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Tuotteita joiden kohde-etuutena tämä arvopaperi

2025 Q4 -tulosraportti

Vain PDF

4 päivää sitten

Uutiset

AI
Viimeisin
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Shareville

Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
  • 1 päivä sitten
    ·
    1 päivä sitten
    ·
    It's really taking off today. I wonder if it's due to the earnings report or because some investors have noticed that it has risen a bit recently?
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    If you have followed this case and thus know its history, you will know - that the case is moving towards the point, this year / next year - where a partnership with one/several regional/international partners from the current valuations will make the case explode. It is pure positioning in HOPE that it actually happens. ....and does it happen then? Who knows, the case is still a pure lottery ticket, nobody can tell...... Having said that, at the same time a lottery ticket for a supplier who has proven to be able to perform quantitative analysis down to the individual sperm cell - and even has a patent on the entire methodology - in an ART market that is predicted by the UN in 2030 to amount to somewhere between 40 and 70 BILLION USD - which in round figures is somewhere between 250 and 450 BILLION DKK in annual ART treatment. Sooo..... that...... Ladies & Gentlemen, Bet's Please!!......
  • 5.2.
    ·
    5.2.
    ·
    It is difficult to come
    9.2.
    ·
    9.2.
    ·
    Many men feel that way😂 apropos this case😂
  • 5.2.
    ·
    5.2.
    ·
    Don't sell too cheaply now. Suddenly it will rise to heights, I believe Spermosens is getting a foothold in several places. This is not a buy recommendation, just a feeling, a strong feeling.
  • 4.2.
    ·
    4.2.
    ·
    Wonder if T06 is advantageous
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    If you like lottery tickets, then buy. I don't really, but you can see in my portfolio how many mio. I have bought.
  • 21.1.
    ·
    21.1.
    ·
    So there have again been a number of news that one can reasonably call positive regarding collaborations (well, non-binding for now). In recent days, there has been a gradual increase up to the level the stock had 6 months ago, which is nice after such a long period of falling prices. It will be very interesting to see if things are turning around for Spermosens now. I think it's too early to say, as there's nothing concrete in the form of contracts, sales or similar, but when/IF it turns around, I have a feeling that there could be some strong price increases. For now, however, I will keep a cool head and wait. I own a number of shares in Spermosens and this is NOT A RECOMMENDATION TO BUY OR THE OPPOSITE, BUT MERELY SOME THOUGHTS. I look forward to the financial report and especially the management's statement on the company's progress.
    22.1. · Muokattu
    ·
    22.1. · Muokattu
    ·
    The global fertility is generally declining - for several reasons, including poor sperm quality. The UN estimates that the average global fertility rate will drop to 2.1 per woman by 2050, which is not that far away. The UN estimates that the world population will stagnate around 2080. .......that was the helicopter view. And now back to something a bit more down-to-earth, there's money in fertility - a lot of money! ChatGPT states that the global ART treatment market in 2030 will amount to somewhere between 40 and 70 BILLION USD - which in round figures is somewhere between 250 and 450 BILLION DKK in annual ART treatment. ........and then there's a small candy shop in Lund that has cracked the code on how quantitative analysis can be performed right down to the individual sperm cell - and they even have a patent on what they're fiddling with☝️☝️ I take the view that the small candy shop constitutes a far more attractive lottery ticket than any product that can be found on spil.dk☝️☝️ .....a lottery ticket, yes - one should certainly not be mistaken about that☝️☝️ In my opinion, the leaflet on that bandit simply states a completely different probability of winning than what can be read on the aforementioned spil.dk☝️☝️ Seen from a TA technical perspective, the case has broken the 20MA upwards on a daily chart level, the same 20MA will break up on a weekly chart level at a closing price over 0.065 - i.e., just a bit above today's closing price. There are technical traders who declare this a buy signal, often in combination with several other signals, including MACD- / RSI- convergence. Personally, I don't attach the same value to it - not least not in a tiny-tiny-candy factory like SPERM - but as the technical trader I am, I naturally can't help but notice the momentum that it also indicates somewhere...... DISCLAIMER: This post should solely be read as my interpretation of the case SPERM constitutes, and should IN NO WAY be perceived as an encouragement to others to invest money in the stock. I have a position in the case. Do your own analyses, and feel free to seek professional guidance before exposing capital in the financial markets, including possibly in SPERM☝️☝️
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

SwedenSpotlight Stock Market SE
Määrä
Osto
1 000 000
Myynti
Määrä
376 693

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
10 638AVAAVA
4 178 113AVAAVA
125 000NONAVA
319 148AVAAVA
255 320AVAAVA
Ylin
0,009
VWAP
0,009
Alin
0,007
VaihtoMäärä
0,6 72 983 419
VWAP
0,009
Ylin
0,009
Alin
0,007
VaihtoMäärä
0,6 72 983 419

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt

Yhtiötapahtumat

Datan lähde: FactSet, Quartr
Seuraava tapahtuma
2026 Q1 -tulosraportti
7.5.
Menneet tapahtumat
2025 Q4 -tulosraportti
11.2.
2025 Q3 -tulosraportti
12.11.2025
2025 Q2 -tulosraportti
20.8.2025
2025 Q1 -tulosraportti
7.5.2025
2024 Q4 -tulosraportti
13.2.2025

Tuotteita joiden kohde-etuutena tämä arvopaperi

2025 Q4 -tulosraportti

Vain PDF

4 päivää sitten

Uutiset

AI
Viimeisin
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Yhtiötapahtumat

Datan lähde: FactSet, Quartr
Seuraava tapahtuma
2026 Q1 -tulosraportti
7.5.
Menneet tapahtumat
2025 Q4 -tulosraportti
11.2.
2025 Q3 -tulosraportti
12.11.2025
2025 Q2 -tulosraportti
20.8.2025
2025 Q1 -tulosraportti
7.5.2025
2024 Q4 -tulosraportti
13.2.2025

Tuotteita joiden kohde-etuutena tämä arvopaperi

Shareville

Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
  • 1 päivä sitten
    ·
    1 päivä sitten
    ·
    It's really taking off today. I wonder if it's due to the earnings report or because some investors have noticed that it has risen a bit recently?
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    If you have followed this case and thus know its history, you will know - that the case is moving towards the point, this year / next year - where a partnership with one/several regional/international partners from the current valuations will make the case explode. It is pure positioning in HOPE that it actually happens. ....and does it happen then? Who knows, the case is still a pure lottery ticket, nobody can tell...... Having said that, at the same time a lottery ticket for a supplier who has proven to be able to perform quantitative analysis down to the individual sperm cell - and even has a patent on the entire methodology - in an ART market that is predicted by the UN in 2030 to amount to somewhere between 40 and 70 BILLION USD - which in round figures is somewhere between 250 and 450 BILLION DKK in annual ART treatment. Sooo..... that...... Ladies & Gentlemen, Bet's Please!!......
  • 5.2.
    ·
    5.2.
    ·
    It is difficult to come
    9.2.
    ·
    9.2.
    ·
    Many men feel that way😂 apropos this case😂
  • 5.2.
    ·
    5.2.
    ·
    Don't sell too cheaply now. Suddenly it will rise to heights, I believe Spermosens is getting a foothold in several places. This is not a buy recommendation, just a feeling, a strong feeling.
  • 4.2.
    ·
    4.2.
    ·
    Wonder if T06 is advantageous
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    If you like lottery tickets, then buy. I don't really, but you can see in my portfolio how many mio. I have bought.
  • 21.1.
    ·
    21.1.
    ·
    So there have again been a number of news that one can reasonably call positive regarding collaborations (well, non-binding for now). In recent days, there has been a gradual increase up to the level the stock had 6 months ago, which is nice after such a long period of falling prices. It will be very interesting to see if things are turning around for Spermosens now. I think it's too early to say, as there's nothing concrete in the form of contracts, sales or similar, but when/IF it turns around, I have a feeling that there could be some strong price increases. For now, however, I will keep a cool head and wait. I own a number of shares in Spermosens and this is NOT A RECOMMENDATION TO BUY OR THE OPPOSITE, BUT MERELY SOME THOUGHTS. I look forward to the financial report and especially the management's statement on the company's progress.
    22.1. · Muokattu
    ·
    22.1. · Muokattu
    ·
    The global fertility is generally declining - for several reasons, including poor sperm quality. The UN estimates that the average global fertility rate will drop to 2.1 per woman by 2050, which is not that far away. The UN estimates that the world population will stagnate around 2080. .......that was the helicopter view. And now back to something a bit more down-to-earth, there's money in fertility - a lot of money! ChatGPT states that the global ART treatment market in 2030 will amount to somewhere between 40 and 70 BILLION USD - which in round figures is somewhere between 250 and 450 BILLION DKK in annual ART treatment. ........and then there's a small candy shop in Lund that has cracked the code on how quantitative analysis can be performed right down to the individual sperm cell - and they even have a patent on what they're fiddling with☝️☝️ I take the view that the small candy shop constitutes a far more attractive lottery ticket than any product that can be found on spil.dk☝️☝️ .....a lottery ticket, yes - one should certainly not be mistaken about that☝️☝️ In my opinion, the leaflet on that bandit simply states a completely different probability of winning than what can be read on the aforementioned spil.dk☝️☝️ Seen from a TA technical perspective, the case has broken the 20MA upwards on a daily chart level, the same 20MA will break up on a weekly chart level at a closing price over 0.065 - i.e., just a bit above today's closing price. There are technical traders who declare this a buy signal, often in combination with several other signals, including MACD- / RSI- convergence. Personally, I don't attach the same value to it - not least not in a tiny-tiny-candy factory like SPERM - but as the technical trader I am, I naturally can't help but notice the momentum that it also indicates somewhere...... DISCLAIMER: This post should solely be read as my interpretation of the case SPERM constitutes, and should IN NO WAY be perceived as an encouragement to others to invest money in the stock. I have a position in the case. Do your own analyses, and feel free to seek professional guidance before exposing capital in the financial markets, including possibly in SPERM☝️☝️
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

SwedenSpotlight Stock Market SE
Määrä
Osto
1 000 000
Myynti
Määrä
376 693

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
10 638AVAAVA
4 178 113AVAAVA
125 000NONAVA
319 148AVAAVA
255 320AVAAVA
Ylin
0,009
VWAP
0,009
Alin
0,007
VaihtoMäärä
0,6 72 983 419
VWAP
0,009
Ylin
0,009
Alin
0,007
VaihtoMäärä
0,6 72 983 419

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt